http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0992241-A4
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-60 |
| filingDate | 1998-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77e191c1da460e736c0e4868a684cb60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc0df39a487cd2a3ce6ba16b9bf62c8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ad7e2b7aa87aa9e112d7e32c681cb74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ba44a9607f69674a5d472e59d2a2e18 |
| publicationDate | 2001-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0992241-A4 |
| titleOfInvention | MEDICAL COMPOSITIONS AGAINST HELICOBACTER PYLORI |
| abstract | An anti-Helicobacter pylori pharmaceutical composition containing a 1-hydroxy-3-methyl-quinolone derivative represented by the following formula (I) <CHEM> or a pharmaceutically acceptable salt thereof as an active ingredient. Since it shows antibacterial action upon Helicobacter pylori, this invention is effective for the treatment or prevention of infection with Helicobacter pylori in human and infection with related bacteria belonging to the genus Helicobacter in animals. Also, the anti-Helicobacter pylori pharmaceutical composition of the present invention is useful for the prevention (including prevention of relapse) or treatment of diseases of the upper digestive organs, such as peptic ulcers (e.g., gastric and duodenal ulcers), inflammations (e.g., acute or chronic gastritis or duodenitis) and gastric cancer, as well as MALT (mucosa-associated lymphoid tissue) lymphoma or chronic heart diseases. |
| priorityDate | 1997-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.